Question Bank › Richer on arrival: the business now flowing in c

Richer on arrival: the business now flowing in carries better economics than the blend the numbers show

Calls Tested
497
Answered YES
25
Hit Rate
5%
rare by design

DuPont de Nemours, Inc. (DD) — this company's answers

NO on the Q1 2016 call 2016-04-26 B+
The model's full reasoning — Q1 2016 call → NOWe need to determine if management conveys that the incoming/ramping business has better economics than the blended results, and that reported numbers understate the company because of mixing with older base or temporary costs. We need to find evidence in the transcript. The question asks specifically about "business NOW ARRIVING OR RAMPING" with better economics. Look for management statements about new products, new technologies, ramping volumes, and whether they indicate better margins/pricing, and whether they say reported results don't yet reflect this. Key points from transcript: - Ed Breen mentions new products in Nutrition & Health: "Supero" protein, Greek yogurts, probiotics up 30%. But does he say these have better economics? He says "new products contributed to growth" and "operating margins expand" in N&H. But not explicitly that these new products have better economics than base. - Jim Collins discusses agriculture: new products like Zorvec fungicide, Leptra insect protected corn hybrids, Roundup Ready 2 Xtend soybeans, CRISPR corn. He says Leptra is "allowing us to recapture price" and "strong value proposition". Also "strong customer interest and aggressive seed production plan have us well-positioned to ramp-up Leptra to as much as a third of our volume in the upcoming summer season". That suggests Leptra is ramping and has better pricing. But does he say reported numbers understate because of mix? He says "we had a good start to the year" but also mentions challenges. He says "we are currently introducing varieties with Roundup Ready 2 Xtend technology in a very limited launch" - that's early. - Also Jim mentions "our first sales of Zorvec" in Q1, and expects it to be competitive. But no explicit statement that these new products have better economics than the base. - Ed Breen says "we delivered operating earnings of $1.26 per share even with last year's quarter. Excluding $0.10 per share of negative currency, operating earnings rose 8%." He attributes strength to Ag and cost savings. He says "most of our businesses exceeded our expectations" but not about new business economics. - Nick Fanandakis discusses cost savings and working capital. No mention of new business economics. - The question is about a coherent story: incoming business is real and economically richer, and reported numbers are a lagging blend.

← Back to the full DD analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business NOW ARRIVING OR RAMPING at the company carries BETTER ECONOMICS than the blended results being reported — and that the reported numbers understate the company because they mix this richer incoming business with an older, lower-economics base or with temporary costs of scaling into it? Answer YES when management's own words convey, in whatever form fits the business, BOTH halves of ONE coherent story as a present-tense reality: (1) THE INCOMING BUSINESS IS REAL AND ECONOMICALLY RICHER. Management describes business that is actually arriving, ramping, or recently begun — real orders, customers, contracts, volumes, locations, products, or activity now flowing, not pipeline, hopes, or market opportunity — AND indicates that this newer business is economically better for the company than the base it is joining: better margins, better pricing or terms, lower cost to serve, faster payback, richer mix, better unit economics, or profitability the older business did not have. The comparison must be against the company's OWN existing or reported blend, expressed in whatever terms fit the industry, and grounded in what is actually being earned or booked now rather than in targets or models. (2) THE REPORTED NUMBERS ARE A LAGGING BLEND, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that the results being reported do not yet show these richer economics — because the new business is still a small share of the mix, because it began recently or mid-period, or because current results also carry identifiable costs of ramping, scaling, onboarding, or standing up that new business ahead of its revenue — so that as the mix naturally shifts and the ramp matures, results improve from what is already in motion rather than from anything still to be won. Answer NO if the improved economics are only targeted, planned, modeled, or hoped for rather than already being realized on real incoming business. NO if the better economics come chiefly from passing through cost inflation, favorable commodity or market prices the company passively receives, or one-time items. NO if the new business is described but management gives no indication it is economically better than the existing blend. NO if the richer business is already the dominant share of results, with no meaningful mix shift or ramp still ahead. NO if the company is chiefly explaining weakness, cutting costs on a shrinking business, or defending a struggling core. NO if the improvement depends mainly on market recovery, new demand not yet secured, or decisions not yet made. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ECPG Encore Capital Group, Inc. Q1 2024 2024-05-08 B
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
HUYA HUYA Inc. Q4 2023 2024-03-19 C
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
AKYA Akoya Biosciences, Inc. Q2 2023 2023-08-07 C+
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
CTO CTO Realty Growth, Inc. Q2 2023 2023-07-28 B
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
CARS Cars.com Inc. Q1 2023 2023-05-06 B
CRBG Corebridge Financial, Inc. Q4 2022 2023-02-22 B
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
FLR Fluor Corporation Q2 2022 2022-08-05 D
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
LC LendingClub Corporation Q4 2021 2022-01-26 A
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
ESS Essex Property Trust, Inc. Q2 2018 2018-08-03 B+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
SATS EchoStar Corporation Q1 2018 2018-05-10 C+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
FLEX Flex Ltd. Q1 2018 2017-07-28 F
DAN Dana Incorporated Q1 2017 2017-05-02 B

How the model reasoned

SPT · Q2 2023 → YESThe question is about whether management conveys that the incoming business has better economics than the blended results, and that reported numbers understate the company because they mix richer inco...YES Management describes real, incoming business (enterprise growth to 43% of ARR, Tagger acquisition, premium attach rates, mid-market unit economics) that is economically richer than the existing blend, with deprioritization of lower-quality low-end ARR.
AKYA · Q2 2023 → YESThe question is: Does management convey that the business NOW ARRIVING OR RAMPING at the company carries BETTER ECONOMICS than the blended results being reported — and that the reported numbers unders...
CRBG · Q4 2022 → YESThe question is: Does management convey that the business NOW ARRIVING OR RAMPING at the company carries BETTER ECONOMICS than the blended results being reported — and that the reported numbers unders...

More from the question bank

Doing it our way nowSelling out of one thing at a timeThe lull that never cameCrossed from claiming to demonstratingFixed price, unfixed volumeEverything is being bought forwardAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.